Nature Communications (Aug 2022)

PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression

  • Ronak Lakhia,
  • Harini Ramalingam,
  • Chun-Mien Chang,
  • Patricia Cobo-Stark,
  • Laurence Biggers,
  • Andrea Flaten,
  • Jesus Alvarez,
  • Tania Valencia,
  • Darren P. Wallace,
  • Edmund C. Lee,
  • Vishal Patel

DOI
https://doi.org/10.1038/s41467-022-32543-2
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 14

Abstract

Read online

ADPKD, a common aetiology of kidney failure, is caused by heterozygous PKD1 or PKD2 mutations. Here the authors show that preventing 3′-UTR cis-inhibition of mRNAs produced by the non-inactivated PKD1/2 alleles ameliorates preclinical ADPKD.